Trial Profile
Pharmacokinetics of Posaconazole in Allogeneic Transplant Patients With Mucositis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 28 Sep 2022
Price :
$35
*
At a glance
- Drugs Posaconazole (Primary)
- Indications Aspergillosis; Candidiasis; Mycoses
- Focus Pharmacokinetics
- 18 Apr 2016 New trial record
- 11 Apr 2016 Results published in the European Journal of Clinical Pharmacology
- 11 Apr 2016 Status changed from recruiting to completed, according to results published in the European Journal of Clinical Pharmacology.